BAC
Bank of America Corporation
BAC has slightly lower modeled downside risk, despite its lower overall score.
EQBK
Equity Bancshares, Inc.
EQBK has a slight edge over BAC overall, supported by stronger fundamentals.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
EQBK Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| N/A | |
| N/A |
EQBK's revenue and profitability are currently strong. Free cash flow and net leverage aren't meaningful measures for financial services companies like EQBK.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over EQBK in the historical PE scenario, which offers more potential upside but is not a forecast.
EQBK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8.4x | $37.06 | -24% |
| Forward | 9.4x | $49.06 | — |
| Fair | 9.9x | $43.90 | -11% |
| Current | 11x | $49.06 | — |
| Expensive | 31x | $138 | +182% |
Historical ranges are pointers, not guarantees.
EQBK's PE is 11x, but its earnings don't support one, so it isn't a reliable read right now.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
BAC has the edge over EQBK on the outlook, with more favorable profitability expectations.
EQBK Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Strong growth | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for EQBK, but weaker profitability.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over EQBK on earnings, with more consistent year-over-year improvement.
EQBK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $5.22 | +18% |
| Q3 2026 | $4.43 | +263% |
| Q2 2026 | $1.59 | -61% |
| Q1 2026 | $1.18 | -70% |
| Q4 2025 | $1.23 | -69% |
| Q3 2023 | $3.02 | -11% |
| Q2 2023 | $3.15 | -3.1% |
| Q1 2023 | $3.35 | +0.3% |
| Q4 2022 | $3.51 | +2.3% |
EQBK's earnings per share have jumped to their highest in six years: $4.43 over the past year, up from $1.22 the year before. Its recent earnings include one-off gains.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC's revenue has grown year over year for 10 quarters in a row: $30B last quarter, up 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
EQBK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $83.7M | +365% |
| Q2 2026 | $81.9M | +40% |
| Q1 2026 | $83.2M | +37% |
| Q4 2025 | $73M | +25% |
| Q3 2025 | $18M | -67% |
| Q2 2025 | $58.4M | +5.3% |
| Q1 2025 | $60.6M | +8.4% |
| Q3 2024 | $55.3M | +11% |
EQBK's revenue has grown year over year for four quarters in a row: $84M last quarter, up 365% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 41% | +248 points |
| Q2 2026 | 41% | +9.7 points |
| Q1 2026 | 27% | -4.4 points |
| Q4 2025 | 36% | +1.3 points |
| Q3 2025 | -207% | -250 points |
| Q2 2025 | 31% | +2.1 points |
| Q1 2025 | 31% | -0.7 points |
| Q4 2024 | 35% | N/A |
EQBK has the edge over BAC on profitability, with a higher operating margin.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
EQBK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $9.9M | +123% |
| Q2 2026 | $35.5M | +37% |
| Q1 2026 | $11.5M | -43% |
| Q4 2025 | -$12.5M | -163% |
| Q3 2025 | $4.5M | -77% |
| Q2 2025 | $26M | +71% |
| Q1 2025 | $20.2M | +90% |
| Q3 2024 | $19.7M | -0.9% |
EQBK has the edge over BAC on cash flow, with more consistent year-over-year improvement.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over EQBK on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
EQBK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -22.7K shares |
| 1 year | +8.7% | +1.7M shares |
| 3 years | +34% | +5.2M shares |
| 5 years | +42% | +6.1M shares |
| Available history | +31% | +5M shares |
EQBK has 21M diluted shares, up 8.7% from a year ago, despite $40M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $9.9M |
| Q1 2026 | $22.7M |
| Q4 2025 | $7.2M |
| Q3 2025 | $6.5M |
| Q2 2025 | $274,000 |
| Q1 2025 | — |
| Q4 2024 | — |
EQBK spent $40M buying back its own shares over the past year, about six times what it spent the year before.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
EQBK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.6x | Healthy |
| Q2 2026 | -0.3x | Net Cash |
| Q1 2026 | -2.1x | Net Cash |
| Q4 2025 | -5.1x | Net Cash |
| Q3 2025 | -8.1x | Net Cash |
| Q2 2025 | 1.0x | Very low |
| Q1 2025 | -0.6x | Net Cash |
| Q4 2024 | -0.9x | Net Cash |
EQBK has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
EQBK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 53.7 | Neutral |
| Stochastic | 45.4 | Neutral |
EQBK's weekly RSI is 54 (neutral) and its Stochastic is 45 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
EQBK PE vs Financial Services Sector
| Metric | EQBK | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 13x | 15% below |
| PE % | 70 | 63 | 7 pts above |
EQBK has the edge over BAC on valuation relative to its sector.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
EQBK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $48.2 | 1.8% above |
| 20 week MA | $49.3 | 0.5% below |
| 50 week MA | $47.2 | 4% above |
| 100 week MA | $43.9 | 12% above |
| 200 week MA | $37.8 | 30% above |
EQBK has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
EQBK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $30.5 | $21.3 | -30% |
| 2021 | $21.3 | $33.3 | +56% |
| 2022 | $33.3 | $32.9 | -1.3% |
| 2023 | $32.9 | $33.9 | +3.2% |
| 2024 | $33.9 | $42.7 | +26% |
| 2025 | $42.7 | $45.7 | +6.9% |
| 2026 YTD | $45.7 | $49.1 | +7.5% |
EQBK has the edge over BAC on returns for 2026, with the stronger performance.